Skylands Capital
BMY icon

Skylands Capital’s Bristol-Myers Squibb BMY Stock Holding History

Skylands Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.17M Sell
131,000
-7,725
-6% -$488K 1.07% 26
2026
Q2 		$7.99M Sell
138,725
-2,675
-2% -$154K 0.98% 34
2026
Q1 		$8.58M Sell
141,400
-1,080
-0.8% -$63K 1.12% 28
2025
Q4 		$7.6M Sell
142,480
-18,400
-11% -$885K 1.03% 30
2025
Q3 		$7.26M Sell
160,880
-5,485
-3% -$256K 1% 31
2025
Q2 		$7.7M Buy
166,365
+23,915
+17% +$1.17M 1.12% 26
2025
Q1 		$8.69M Sell
142,450
-21,225
-13% -$1.24M 1.25% 23
2024
Q4 		$9.26M Sell
163,675
-17,400
-10% -$972K 1.29% 22
2024
Q3 		$9.37M Sell
181,075
-39,725
-18% -$1.86M 1.27% 19
2024
Q2 		$9.17M Buy
220,800
+32,150
+17% +$1.44M 1.3% 21
2024
Q1 		$10.2M Buy
188,650
+9,625
+5% +$490K 1.41% 19
2023
Q4 		$9.19M Sell
179,025
-17,875
-9% -$938K 1.35% 18
2023
Q3 		$11.4M Buy
196,900
+14,850
+8% +$910K 1.73% 12
2023
Q2 		$11.6M Sell
182,050
-4,975
-3% -$334K 1.67% 13
2023
Q1 		$13M Buy
187,025
+71,800
+62% +$5.06M 1.9% 12
2022
Q4 		$8.29M Sell
115,225
-11,275
-9% -$850K 1.31% 20
2022
Q3 		$8.99M Sell
126,500
-4,400
-3% -$319K 1.48% 15
2022
Q2 		$10.1M Sell
130,900
-36,620
-22% -$2.79M 1.48% 18
2022
Q1 		$12.2M Sell
167,520
-32,025
-16% -$2.15M 1.48% 17
2021
Q4 		$12.4M Buy
199,545
+16,825
+9% +$987K 1.44% 17
2021
Q3 		$10.8M Sell
182,720
-19,500
-10% -$1.28M 1.34% 19
2021
Q2 		$13.4M Sell
202,220
-11,400
-5% -$743K 1.59% 15
2021
Q1 		$13.5M Buy
213,620
+23,810
+13% +$1.48M 1.72% 16
2020
Q4 		$11.8M Buy
189,810
+29,550
+18% +$1.82M 1.71% 18
2020
Q3 		$9.6M Buy
160,260
+14,800
+10% +$891K 1.6% 17
2020
Q2 		$8.55M Buy
145,460
+103,470
+246% +$6.19M 1.51% 16
2020
Q1 		$2.34M Sell
41,990
-250
-0.6% -$15.3K 0.52% 44
2019
Q4 		$2.69M Buy
+42,240
New +$2.42M 0.39% 55

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Skylands Capital's BMY Position: Q3 2026 in Review

Skylands Capital reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q3 2026, selling an estimated $488K and leaving 131,000 shares worth $8.17M. The position accounts for 1.07% of the portfolio, ranked #26.

Skylands Capital first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $13.5M in Q1 2021. 1,727 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Skylands Capital held 131,000 shares of Bristol-Myers Squibb worth $8.17M as of Q3 2026.
  • Skylands Capital sold 7,725 Bristol-Myers Squibb shares in Q3 2026, an estimated $488K.
  • Bristol-Myers Squibb made up 1.07% of Skylands Capital's portfolio in Q3 2026, its #26 holding.
  • Skylands Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
  • Skylands Capital's Bristol-Myers Squibb position peaked at $13.5M in Q1 2021.
  • 1,727 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Skylands Capital's 13F filing for Q3 2026, filed 21 Oct 2026.